Skip to main content

Table 3 Patients’ characteristics

From: MicroRNAs in urine are not biomarkers of multiple myeloma

 

HD

RCC

MM

No. of patients/donors

22

7

56

Gender: males-females

9-13

6-1

28-28

Age median (min-max) [years]

57 (50–90)

61 (27–83)

69 (49–89)

ISS stage: I-II-III

ND

ND

16-12-19

D-S stage: I-II-III

ND

ND

3-7-40

D-S substage: A-B

ND

ND

39-11

Ig isotype: IgG-IgA-FLC

ND

ND

34-11-10

Light chains: kappa-lambda

ND

ND

40-15

Amount of M-Ig/FLC g/l median (min-max)

ND

ND

25,45 (0,17-65,4)

PCs infiltration in BM

ND

ND

13,1 (0,14-87,4)

No treatment

ND

ND

56 (100 %)

  1. ND – not done, ISS stage – International Staging System stage, D-S stage – Durie-Salmon stage, M-Ig – monoclonal immunoglobulin, FLC – Free Light Chains